Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway

Lisa Maria Kuhn, Cyrill Schipp, PhD, Daniel Hein, PhD, Bianca Killing, Nan Qin, PhD, Vera H Jepsen, M.Sc., Heinz Ahlert, MSc, BSc, Jasmin Bartl, PhD, Viktoria Marquardt, M.Sc., David Pauck, Kai Völtzke, M.Sc., Jonathan Lim, PhD, Gabriel Leprivier, PhD, Marc Remke, MD, Sanil Bhatia, PhD, Thorsten Rosenbaum, MD, Arndt Borkhardt, MD, Ute Fischer, PhD

Blood (2019) 134 (Supplement_1): 4651.

https://doi.org/10.1182/blood-2019-131406

Published: 2019

Journal Articles

The Landscape of Circular RNAs in Drug Resistant TCF3 -Rearranged Childhood Leukemia

Cai Chen, Daniel Picard, M.Sc., Nan Qin, PhD, Cyrill Schipp, MSc, Michael Gombert, PhD, Sebastian Ginzel, M.Sc., Jianda Hu, Prof MDPhD, Arndt Borkhardt, Prof MD, Marc Remke, Ute Fischer, PhD

Blood (2017) 130 (Supplement 1): 1432.

https://doi.org/10.1182/blood.V130.Suppl_1.1432.1432

Published: 2017

Journal Articles

Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing

Cyrill Schipp, MSc, Arndt Borkhardt, MD, Polina Stepensky, MD, Ute Fischer, PhD

Blood (2016) 128 (22): 3706.

https://doi.org/10.1182/blood.V128.22.3706.3706

Published: 2016

Journal Articles

2% of Healthy Newborns Reveal ETV6-RUNX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL)

Daniel Schaefer, MSc, Marianne Olsen, MD, Ulrik Lausten-Thomsen, MD PhD, Cyrill Schipp, MSc, Martin Stanulla, MD, Robert K. Slany, PhD, Kjeld Schmiegelow, MD DMSc, Arndt Borkhardt, MD, Ute Fischer, PhD

Blood (2016) 128 (22): 4082.

https://doi.org/10.1182/blood.V128.22.4082.4082

Published: 2016

Journal Articles

Activating Mutation of STAT3 Protects Lymphocytes from Apoptosis and Leads to a Clinical Phenotype Resembling the Autoimmune Lymphoproliferative Syndrome

Schafiq Nabhani, PhD, Hagit Miskin, MD, Cyrill Schipp, MSc, Dan Harlev, Shoshana Revel-Vilk, MD MSc, Michael Gombert, PhD, Sebastian Ginzel, MSc, Arndt Borkhardt, MD, Polina Stepensky, MD, Ute Fischer, PhD

Blood (2015) 126 (23): 2218.

https://doi.org/10.1182/blood.V126.23.2218.2218

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway

The Landscape of Circular RNAs in Drug Resistant TCF3 -Rearranged Childhood Leukemia

Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing

2% of Healthy Newborns Reveal ETV6-RUNX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL)

Activating Mutation of STAT3 Protects Lymphocytes from Apoptosis and Leads to a Clinical Phenotype Resembling the Autoimmune Lymphoproliferative Syndrome

Email alerts

ASH Publications

American Society of Hematology

Update search

Investigation of New Therapeutic Compounds for Juvenile Myelomonocytic Leukemia Using Induced Pluripotent Stem Cells with Stably Activated Ras Pathway

The Landscape of Circular RNAs in Drug Resistant TCF3 -Rearranged Childhood Leukemia

Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing

2% of Healthy Newborns Reveal ETV6-RUNX1 Fusion By Genomic Inverse PCR for Exploration of Ligated Breakpoints (GIPFEL)

Activating Mutation of STAT3 Protects Lymphocytes from Apoptosis and Leads to a Clinical Phenotype Resembling the Autoimmune Lymphoproliferative Syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only